Drug Profile
Coronavirus vaccines - Brighton Biotech
Alternative Names: MERS-CoV vaccine - Brighton; Middle east respiratory syndrome - Brighton; SARS-CoV vaccine - Brighton; Severe acute respiratory syndrome - BrightonLatest Information Update: 31 Aug 2023
Price :
$50
*
At a glance
- Originator Baylor College of Medicine; Sabin Vaccine Institute; Texas Children's Hospital Center for Vaccine Development
- Developer Baylor College of Medicine; Sabin Vaccine Institute
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Middle East respiratory syndrome coronavirus; Severe acute respiratory syndrome
Most Recent Events
- 24 Aug 2023 Discontinued - Preclinical for Middle East respiratory syndrome coronavirus (Prevention) in USA (unspecified route)
- 24 Aug 2023 Discontinued - Preclinical for Severe acute respiratory syndrome (Prevention) in USA (unspecified route)
- 28 Nov 2019 No recent reports of development identified for preclinical development in Middle-East-respiratory-syndrome-coronavirus(Prevention) in USA